Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Final Product Inspection for Granules

Posted on By

SOP for Final Product Inspection for Granules

Standard Operating Procedure for Final Product Inspection for Granules

1) Purpose

The purpose of this SOP is to define procedures for conducting final product inspection of granules in the pharmaceutical industry to ensure compliance with quality standards and specifications before release.

2) Scope

This SOP applies to all personnel involved in final product inspection activities for granules within the pharmaceutical manufacturing facility.

3) Responsibilities

Quality Control (QC) Department: Responsible for performing final product inspection and releasing materials based on inspection results.
Production Supervisors: Responsible for coordinating final inspection activities.
Operators and Technicians: Responsible for assisting in the inspection process and documenting results.

See also  SOP for Stability Testing of Granules

4) Procedure

  1. Sampling:
    1. Select random samples of finished granules batches according to sampling plan.
    2. Ensure samples are representative and properly labeled.
  2. Inspection Criteria:
    1. Verify physical characteristics such as color, appearance, and uniformity of granules.
    2. Perform tests for critical quality attributes such as assay, particle size distribution, and moisture content.
  3. Documentation:
    1. Record inspection results accurately in batch records or electronic systems.
    2. Document any deviations or discrepancies found during inspection.
  4. Decision Making:
    1. Compare inspection results against predefined acceptance criteria.
    2. Make decisions on batch disposition (release, reject, or rework) based on inspection findings.
  5. Approval and Release:
    1. Submit inspection results and documentation to QA for review and approval.
    2. Release conforming batches for further processing or distribution.
See also  SOP for Particle Morphology Testing in Powders

5) Abbreviations, if

any

SOP: Standard Operating Procedure
QC: Quality Control

6) Documents, if any

Sampling Plan, Batch Records, Inspection Reports

7) Reference, if any

Good Manufacturing Practice (GMP) guidelines for pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Powder & Granules Tags:analytical method development granules, assay of active ingredient granules, bulk density testing granules, contamination prevention powder, documentation in powder manufacturing, equipment cleaning for powders, final product inspection powder, flowability testing powders, formulation development granules, granulation stability testing, granule calibration SOP, granule production procedure, granule quality control SOP, homogeneity testing granules, in-process testing granules, microbial testing powder, particle size distribution powders, pharmaceutical powder handling, powder blending protocol, powder manufacturing SOP, powder packaging guidelines, powder storage conditions, process optimization powders, process validation powders, raw material inspection powders, sample collection for powders, SOP for granulation techniques, sterility in granule production, training SOP for granule production, waste disposal in granule production

Post navigation

Previous Post: SOP for Suppository Transfer Conveyor
Next Post: SOP for Homogeneity Testing in MDIs

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version